107 related articles for article (PubMed ID: 17137889)
1. Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa.
Misra M; Miller KK; Tsai P; Stewart V; End A; Freed N; Herzog DB; Goldstein M; Riggs S; Klibanski A
J Pediatr; 2006 Dec; 149(6):763-769. PubMed ID: 17137889
[TBL] [Abstract][Full Text] [Related]
2. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.
Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P
Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
[TBL] [Abstract][Full Text] [Related]
5. Hormonal and nutritional effects on cardiovascular risk markers in young women.
Lawson EA; Miller KK; Mathur VA; Misra M; Meenaghan E; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2007 Aug; 92(8):3089-94. PubMed ID: 17519306
[TBL] [Abstract][Full Text] [Related]
6. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
8. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
[TBL] [Abstract][Full Text] [Related]
9. [Levels of apoproteins B, A1 and CIII as markers for cardiovascular risk in lean and obese adolescents].
Fernández V; Morales LM; Molero-Conejo E; Casanova A; Campos G; Raleigh X; Gómez ME; Ryder E
Invest Clin; 2004 Mar; 45(1):29-42. PubMed ID: 15058756
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cardiovascular disease in patients with anorexia nervosa.
Matzkin V; Slobodianik N; Pallaro A; Bello M; Geissler C
Int J Psychiatr Nurs Res; 2007 Sep; 13(1):1531-45. PubMed ID: 17927021
[TBL] [Abstract][Full Text] [Related]
11. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
[TBL] [Abstract][Full Text] [Related]
12. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
13. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
14. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
[TBL] [Abstract][Full Text] [Related]
16. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
Walldius G; Jungner I
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
[TBL] [Abstract][Full Text] [Related]
17. Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein.
Sung KC; Kang JH; Shin HS
Arch Med Res; 2007 Jan; 38(1):121-5. PubMed ID: 17174735
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
19. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
Akbartabartoori M; Lean ME; Hankey CR
Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
[TBL] [Abstract][Full Text] [Related]
20. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
